We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · November 01, 2020

CGRP Monoclonal Antibody Use for Preventing Refractory Headache in Adolescents

Pediatric Neurology


Additional Info

Disclosure statements are available on the authors' profiles:

Pediatric Neurology
CGRP Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents
Pediatr. Neurol. 2020 Oct 05;[EPub Ahead of Print], KA Greene, CP Gentile, CL Szperka, et al

Further Reading